Regorafenib

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Big changes at Teva; FDA approves one of the world’s costliest drugs

This week, Phispers brings you news about hefty pay packages at AstraZeneca and Mylan; FDA’s F

US DMF filings indicate a robust API industry, with multiple first-to-file challenges

This week, PharmaCompass brings you a compilation of the Drug Master Files (DMFs) updates at